Voyager Therapeutics (VYGR) Priced

Gene therapy biotech targeting Parkinson's disease and other CNS disorders.

Health Care - Biotechnology

IPO Performance
Latest Trade $12.29 0.00 (0.0%)
First Day Return 26.8%
Return from IPO -12.2%
 
Voyager Therapeutics IPO News more
  • .
IPO Data
IPO File Date 10/09/2015
Offer Price $14.00
Price Range $15.00 - $17.00
Offer Shares (mm) 5.0
Deal Size ($mm) 70
 
IPO Data
IPO Date 11/10/2015
Offer Price $14.00
Price Range $15.00 - $17.00
Offer Shares (mm) 5.0
Deal Size ($mm) $70
 
Underwriters
more
Business Overview
Gene therapy biotech targeting Parkinson's disease and other CNS disorders.
Gene therapy biotech targeting Parkinson's disease and other CNS disorders.
more
Company Data
Headquarters Cambridge, MA
Founded 2013
Employees 48
Website www.voyagertherapeutics.com
 

Performance vs. IPO Index (IPOUSA)